PT PALVELLA THERAPEUTICS, INC. Stock: price and directors' dealings · United States · SEC (Form 4)Track the PALVELLA THERAPEUTICS, INC. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.4bn. The latest transaction was filed on 20 August 2026 (Levée d'options). Among the most active insiders: Goin Kathleen. The full history is openly available.
Analyst consensus: bullish or bearish? Analysts rate PALVELLA THERAPEUTICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 August 2026
All Executives34 Thresholds0 Prospectus0 Other0
Declarations 34 total
◇ Chief Operating Officer · Executives · 19 Aug 2026
2,154 shares @ US$7.14 Common Stock SEC:0001104659-26-099222:0
◇ Chief Operating Officer · Executives · 19 Aug 2026
2,148 shares @ US$9.08 Common Stock SEC:0001104659-26-099222:1
▼ Chief Operating Officer · Executives · 19 Aug 2026
1,500 shares @ US$151.39 Common Stock SEC:0001104659-26-099222:2
▼ Chief Operating Officer · Executives · 19 Aug 2026
1,998 shares @ US$151.7979 Common Stock SEC:0001104659-26-099222:3
▼ Chief Operating Officer · Executives · 19 Aug 2026
400 shares @ US$152.9975 Common Stock SEC:0001104659-26-099222:4
▼ Chief Operating Officer · Executives · 19 Aug 2026
102 shares @ US$155.5898 Common Stock SEC:0001104659-26-099222:5
▼ Chief Operating Officer · Executives · 19 Aug 2026
302 shares @ US$156.77 Common Stock SEC:0001104659-26-099222:6
● Officer · Executives · 19 Aug 2026
4,302 shares @ US$150.42 0.028% mcap 20.8% of flow Common Stock SEC144:0001967940-26-000044
▼ Chief Operating Officer · Executives · 15 Jul 2026
840 shares @ US$148.4018 0.0065% mcap 5.1% of flow Common Stock SEC:0001104659-26-084620:3
◇ Chief Operating Officer · Executives · 15 Jul 2026
2,154 shares @ US$7.14 0.0008% mcap 0.6% of flow Common Stock SEC:0001104659-26-084620:0
◇ Chief Operating Officer · Executives · 15 Jul 2026
2,148 shares @ US$9.08 0.0010% mcap 0.8% of flow Common Stock SEC:0001104659-26-084620:1
▼ Chief Operating Officer · Executives · 15 Jul 2026
522 shares @ US$147.1365 0.0040% mcap 3.2% of flow Common Stock SEC:0001104659-26-084620:2
▼ Chief Operating Officer · Executives · 15 Jul 2026
1,029 shares @ US$149.2667 0.0080% mcap 6.3% of flow Common Stock SEC:0001104659-26-084620:4
▼ Chief Operating Officer · Executives · 15 Jul 2026
1,911 shares @ US$150.2529 0.015% mcap 11.8% of flow Common Stock SEC:0001104659-26-084620:5
● Officer · Executives · 15 Jul 2026
4,302 shares @ US$149.68 0.034% mcap 36.7% of flow Common Stock SEC144:0001967940-26-000039
● Officer · Executives · 17 Jun 2026
4,302 shares @ US$110.7329 0.024% mcap 42.6% of flow Common Stock SEC144:0001967940-26-000032
▼ Chief Operating Officer · Executives · 15 Apr 2026
1,500 shares @ US$127.1254 0.0096% mcap 32.7% of flow Common Stock SEC:0001104659-26-044895:3
▼ Chief Operating Officer · Executives · 15 Apr 2026
561 shares @ US$128.2349 0.0036% mcap 12.4% of flow Common Stock SEC:0001104659-26-044895:4
▼ Chief Operating Officer · Executives · 15 Apr 2026
639 shares @ US$129.1692 0.0042% mcap 14.2% of flow Common Stock SEC:0001104659-26-044895:5
▼ Chief Operating Officer · Executives · 15 Apr 2026
100 shares @ US$130.33 0.0007% mcap 2.2% of flow Common Stock SEC:0001104659-26-044895:6
◇ Chief Operating Officer · Executives · 15 Apr 2026
2,154 shares @ US$7.14 0.0008% mcap 2.6% of flow Common Stock SEC:0001104659-26-044895:0
◇ Chief Operating Officer · Executives · 15 Apr 2026
2,148 shares @ US$9.08 0.0010% mcap 3.3% of flow Common Stock SEC:0001104659-26-044895:1
▼ Chief Operating Officer · Executives · 15 Apr 2026
1,502 shares @ US$125.9647 0.0096% mcap 32.5% of flow Common Stock SEC:0001104659-26-044895:2
▲ Director · Executives · 30 Mar 2026
445 shares @ US$112.30 31.4% of flow Common Stock SEC:0001104659-26-038496:0
Canonical exit: 28 Jun 2026 (T+90) ◇ Chief Operating Officer · Executives · 18 Mar 2026
2,154 shares @ US$7.14 2.6% of flow Common Stock SEC:0001104659-26-032695:0
25 of 34 declarations
Load more (9 remaining) About PALVELLA THERAPEUTICS, INC. PALVELLA THERAPEUTICS, INC. is a company focused on developing treatments for autoimmune diseases. It is listed on NASDAQ under the ticker XNAS.